nantkwest.com | Immunotherapy by ImmunityBio

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://immunitybio.com/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	Immunotherapy by ImmunityBio - Cell Therapy for
Description	Researching Ways to Prevent ImmunityBio is dedicated to conquering cancer. We develop therapies that kill disease, not the immune system. Learn about our investigational immunotherapy and cell therapy
Keywords	N/A

Server Information

WebSite	nantkwest.com
Host IP	74.206.101.41
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

nantkwest.com Valuation

US$1,470

Last updated: 2023-05-12 22:52:56

nantkwest.com has Semrush global rank of 0. nantkwest.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. nantkwest.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 74.206.101.41. According to SiteAdvisor, nantkwest.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,470
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$40
Yearly Ads Revenue	US$488
Daily Unique Visitors	11
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
nantkwest.com.	A	3600	IP: 74.206.101.41
nantkwest.com.	NS	3600	NS Record: pdns12.domaincontrol.com.
nantkwest.com.	NS	3600	NS Record: pdns11.domaincontrol.com.
nantkwest.com.	MX	600	MX Record: 0 smtp4.nantworks.com.
nantkwest.com.	MX	600	MX Record: 0 smtp3.nantworks.com.
nantkwest.com.	TXT	600	TXT Record: adobe-idp-site-verification=cb770e05fab37726c9771a32ddd6bb422995b8e10b2e5b46f12ebe50a204d28a
nantkwest.com.	TXT	600	TXT Record: ZOOM_verify_FPX1YvD3QMCyvjHEQhko0w
nantkwest.com.	TXT	600	TXT Record: apple-domain-verification=u39OINfUaxVFTFUj
nantkwest.com.	TXT	600	TXT Record: KpUFV0gLEwd5c7F2/G0LacA+EAkicyDb0o2sj3aJhJ5Jh79L59JkvEbj8gzCVb0s21aSgl0ZcFWqzSK+xkW+0g==
nantkwest.com.	TXT	600	TXT Record: v=spf1 mx ip4:8.29.9.8 ip4:208.74.224.234 ip4:185.130.236.98 ip4:74.206.101.37 ip4:208.74.224.149 ip4:208.74.224.150 ip4:74.206.101.58 ip4:74.206.101.59 ip4:74.206.101.52 ip4:74.206.101.53 mx:nantworks.com include:servers.mcsv.net -all
nantkwest.com.	TXT	600	TXT Record: MS=ms79148802

HtmlToTextCheckTime:2023-05-12 22:52:56

Our Science Platforms Pipeline Expanded Access Research Unique Approach Patients Trial Investigators Researchers Therapies Bladder Cancer Glioblastoma Lynch Syndrome Non-Small Cell Lung Cancer Pancreatic Cancer COVID-19 HIV Our Company About Us Investors News Contact Careers Get Started Find a Trial Become a Trial Investigator License our Cells Select Page Researching Ways to Prevent Cancer ImmunityBio is working with the National Cancer Institute on the largest Lynch syndrome cancer prevention study in the U.S. People with hereditary Lynch syndrome can develop colorectal cancer decades earlier than average, and have increased risk of developing additional cancers. Learn More Finding Better Treatments for Bladder Cancer We are pleased to report that the FDA has accepted for review our BLA for N-803 + BCG for BCG-Unresponsive NMIBC CIS. If approved, N-803 plus BCG would be the first immunotherapy combination for this indication in 23 years that can be delivered directly to the bladder

HTTP Headers

HTTP/1.1 302 Found
Date: Mon, 20 Dec 2021 04:58:45 GMT
Server: Apache/2.4.46 (IUS) OpenSSL/1.0.2k-fips PHP/7.4.19
Strict-Transport-Security: max-age=15768000
X-Frame-Options: SAMEORIGIN
Location: https://immunitybio.com/
Cache-Control: max-age=86400
Expires: Tue, 21 Dec 2021 04:58:45 GMT
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
date: Mon, 20 Dec 2021 04:58:49 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 10
x-cache-group: normal
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=BNIcpKiHRUqsqmpg3qI91RLTqOvprVdM56gnFKXeuEXfNsOqZOg3jygEnj3jUXT3ZzcN7MCuEDeMlojeos%2BYjPYNFtn4DGLZNUrOZeWnH6PDiOqWW6SImLMUpCAjaUVXcQ%3D%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c064c381cb5190a-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

nantkwest.com Whois Information

Domain Name: NANTKWEST.COM
Registry Domain ID: 1943621181_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-07-08T19:45:52Z
Creation Date: 2015-07-01T06:17:52Z
Registry Expiry Date: 2023-07-01T06:17:52Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS11.DOMAINCONTROL.COM
Name Server: PDNS12.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-23T07:47:52Z <<<

nantkwest.com valuation and analysis